Advertisement
Advertisement
TOPIC

National Medical Products Administration (China)

National Medical Products Administration (China)
The latest news and top stories on National Medical Products Administration. A prominent Beijing, China-based governmental regulatory agency, the National Medical Products Administration (NMPA) is dedicated to safeguarding public health by regulating drugs, medical devices, and cosmetics. Its primary mission involves ensuring the safety and efficacy of these products through comprehensive approval, registration, and post-market supervision. The NMPA’s main areas of activity include setting standards, conducting inspections, and managing adverse event monitoring.
China’s private sector

China’s obesity drug makers take on global giants as Novo Nordisk patent expires

Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market.

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

China’s Hengrui gets boost from fifth drug-licensing deal of year

Shares rise after Mumbai-based Glenmark Pharmaceuticals strikes deal for cancer drug.

China’s biotech industry is gaining on the US. Can tariffs hold them back?

Pharmaceutical firms in China have grown fast, but geopolitics and a long head start could keep US-based leaders at industry apex - for now.

videocam
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement